Oramed Pharmaceuticals Inc.

8-K Amended charter or bylaws; Other events Jun 30, 2026 10-Q Quarter ended 2026-03-31 May 19, 2026 8-K Entered a material agreement; Completed an acquisition or disposition Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Entered a material agreement Feb 20, 2026 8-K Entered a material agreement; Other events Jan 14, 2026 8-K Other events Jan 7, 2026 8-K Director or officer change Dec 31, 2025 8-K Other events Dec 31, 2025 8-K Results of operations (earnings release) Nov 17, 2025 8-K Entered a material agreement; Modified rights of security holders Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Other events Oct 24, 2025 8-K Other events Oct 6, 2025 8-K Director or officer change; Shareholder vote results Aug 21, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Other events Jul 23, 2025 10-K/A Fiscal year ended 2024-12-31 Jul 16, 2025 8-K Other events May 21, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement; Regulation FD disclosure Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Entered a material agreement Mar 3, 2025 8-K Entered a material agreement Feb 27, 2025 8-K Entered a material agreement; Regulation FD disclosure Feb 11, 2025 8-K Entered a material agreement Jan 22, 2025 8-K Entered a material agreement Jan 3, 2025 8-K Other events Dec 17, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Other events Oct 29, 2024 8-K Entered a material agreement; Regulation FD disclosure; Other events Oct 8, 2024 8-K Entered a material agreement Sep 26, 2024 8-K Other events Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Shareholder vote results Aug 2, 2024 8-K Other events Jun 26, 2024 8-K Other events Jun 24, 2024 8-K Director or officer change Jun 10, 2024 8-K Director or officer change May 13, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024